Amiodarone and risk of liver cirrhosis: a nationwide, population-based study
Ching-Hui Huang,1–3,* Ya-Yun Lai,4,* Yu-Jui Kuo,4,5 Su-Ching Yang,6 Yu-Jun Chang,7 Kuo-Kuan Chang,8 Wen-Kang Chen4 1Division of Cardiology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 2Department of Beauty Science, Graduate Institute of Beauty Science Te...
Guardado en:
Autores principales: | Huang CH, Lai YY, Kuo YJ, Yang SC, Chang YJ, Chang KK, Chen WK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05f5ce2653f947ea9df1964817caf639 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Multidisciplinary Team Approach to the Treatment of Liver Cirrhosis
por: Zhang YR, et al.
Publicado: (2021) -
Silymarin's Defensive Role Against Hepatotoxicity induced By Amiodarone In Albino Rats
por: Eid,Refaat A, et al.
Publicado: (2021) -
Assessment of Pyroptosis-Related Indicators as Potential Biomarkers and Their Association with Severity in Patients with Liver Cirrhosis
por: Wang D, et al.
Publicado: (2021) -
Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
por: E. S. Eniseeva
Publicado: (2019) -
Control of Tissue Fibrosis by 5-Methoxytryptophan, an Innate Anti-Inflammatory Metabolite
por: Kenneth K Wu, et al.
Publicado: (2021)